Cheap Cialis Blogger | Search results for "nanotechnology"

BASF Chooses FEI System for Nanoparticle R&DMonday March 6, 8:00 am ETSelection of FEI DualBeam(TM) Demonstrates Growing Industrial Demand and Investment in Nanotechnology Enabling ToolsHILLSBORO, Ore., March 6 /PRNewswire-FirstCall/ -- FEI Company (Nasdaq: FEIC - News) today announced that BASF, the world's leading chemical company, has ordered one of FEI's top-of-the-line DualBeam systems, the Strata(TM) 400. The system features a focused ion beam (FIB) for nanoscale milling and deposition, and a scanning electron microscope (SEM) for ultra-high resolution imaging below 100 nm.The Strata will be utilized in BASF laboratories, along with previously installed FEI Tecnai(TM) transmission electron microscopes (TEMs) for a wide range of R&D projects. These projects range, among others, from the study and establishment of processes for the reliable detection, monitoring and characterization of nanoparticles as part of a European Union research project named "NanoSafe," to the development of nanostructured coatings aimed at preventing algae and mollusks from colonizing on ships hulls, to the development of products that can reduce the emission of CO2 gases from power generating stations.Underscoring BASF's commitment to nanotechnology R&D, Dr. Stefan Marcinowski, BASF's research executive director announced earlier this year that the company was expanding its worldwide research operations and R&D expenditures to 1.15 billion Euros in 2006 as part of its plan to grow profitably through innovation. Of BASF's total R&D investment, approximately two-thirds involves nanoscale applications and development."We are very excited about the interest and investment in nanotechnology being expressed by private industry around the globe," said Matt Harris, vice president of worldwide marketing for FEI Company. "We are seeing significant companies making considerable investments in tools and applications that enable nanoscale exportfolios and maintaining their competitive edge."Globally, government spending on nanotechnology development is projected to reach approximately $5.0 billion (U.S.) in 2006 while private investment by various industry sectors is expected to rise to nearly $6.0 billion in the same period.About BASFBASF is the world's leading chemical company: The Chemical Company. Its portfolio ranges from chemicals, plastics, performance products, agricultural products and fine chemicals to crude oil and natural gas. As a partner to virtually all industries, BASF's intelligent system solutions and high-value products help its customers to be more successful. BASF develops new technologies and uses them to open up additional market opportunities. It combines economic success with environmental protection and social responsibility, thus contributing to a better future. In 2005, BASF had approximately 81,000 employees and posted sales of more than euro 42.7 billion. BASF shares are traded on the stock exchanges in Frankfurt (BAS), London (BFA), New York (BF) and Zurich (AN). Further information on BASF is available on the Internet at www.basf.com.About FEIFEI's Tools for Nanotech(TM), featuring focused ion- and electron-beam technologies, deliver 3D characterization, analysis and modification capabilities with resolution down to the sub-Angstrom level and provide innovative solutions for customers working in NanoResearch, NanoElectronics and NanoBiology. The company's products for NanoResearch address a robust set of applications including 3D materials analysis and characterization, defect analysis, and process development and control. With R&D centers in North America and Europe, and sales and service operations in more than 40 countries around the world, FEI is bringing the nanoscale within the grasp of leading researchers and manufacturers and helping to turn some of the biggest ideas of this century into reality. More information can be found on the FEI website at: http://www.feicompany.com .Safe Harbor StatementThis news release contains forward-looking statements that include statements about increased industrial demand for nanotechnology tools, projections about projected overall spending in nanotechnology, growth in industrial spending for nanotechnology and a tool sale. Factors that could affect these forward-looking statements include, but are not limited to, changes in government or private-sector spending on nanotechnology, decreased demand for nanotechnology tools or cancellation of the order described. Please refer to our Form 10-K, Forms 10-Q, Forms 8-K and other filings with the U.S. Securities and Exchange Commission for additional information on these factors and other factors that could cause actual results to differ materially from the forward-looking statements. FEI assumes no duty to update forward-looking statements. Levitra

Tags: nanotechnology, statements, forward, basf, spending

Abraxis BioScience, Inc. (ABBI-$21.45) provides a unique opportunity for investment in a biopharmaceutical company revolutionizing cancer therapy with its proprietary nanotechnology platform. Abaxis buy cilais buy cheap cialis generic cialis

Tags: cialis, abraxis, bioscience, buy, therapy

Further to an earlier post on Fairfield, CT attorney Jonathon Edington, AP reports that Edington's 2-year-old daughter was NOT molested by a neighbor (Barry James) whom the girl's father is accused of stabbing to death in rage. Capt. Gary MacNamara: "We're confident this 2-year-old was not molested. We are confident in our investigation that Mr. Edington did in fact kill Mr. James. " ***Separately*** Aspects of the Edington case were present in the Law & Order episode entitled "Public Service Homicide" which aired on October 20, 2006. The analog of the victim Barry James in the Edington case was one Carl Mullaly, who was stabbed to death. Unlike in the Edington case, the victim on Law and Order had been exposed on a tv show "Hard Focus," which bore similarity to certain recent episodes of NBC's Dateline. In Law & Order, there was a neighbor (Evan Fleming) who had a daughter. The character Fleming was a doctor, rather than a patent lawyer. On Law & Order, the neighbor doctor was not the murderer. On Law & Order, there was also an organization ScumWatch. Curiously, the police on Law & Order conveyed lines not supportive of "Hard Focus": "train wreck tv" and "problem with your show inciting violence." As the episode of Law & Order progressed, it became apparent that "Hard Focus" had significant involvement in the murder. It turned out that the true murderer (Hannah Welch) had significant involvement with the producer of Hard Focus, Elle (L.A.?) Harper. Harper was working on a different show "Confront and Heal," and had identified Welch as one who had been raped by Mullaly. McCoy noted: The distinction between news and entertainment is not so clear. Planting pseudonews on the news without disclaimer is not proper [IPBiz: reminds one of the July 28 "news of the week" in Science; see 88 JPTOS 743]. An event where one of the participants is trained, paid, and armed by the producer is not journalism. It's not entertainment; it's murder. Harper was convicted of second degree murder. There was even an IP angle in the show. The lawyer for Hard Focus initially objected to turning over tapes to the prosecutor on the basis that they contained trade secrets. Law & Order also mentioned Krav Mega.

Tags: edington, molested, murder, patent, year

Sun setting on nanotechnology patents??? Jon Van of the Chicago Tribune, in an article Slow patent process hurts nanotech progress; Financial backers wary of 4-year filing period presents the quote: "The impact is one of perception. When you don't get a response from a patent application filing, you don't know what else is going on." There is also text: Bruce Kisliuk, director of a patent examining group at the patent office, said the agency does face a growing backlog across all areas. "We have 700,000 applications in the pipeline," Kisliuk said. "Some are for nanotech, some not. This backlog isn't unique to nanotech." Last year, the office issued fewer patents than usual because of an initiative to improve patent quality, Kisliuk said. Note the following text about the hiring of examiners: After years of being starved for resources, the office, which has had around 4,000 examiners, hired 1,200 new ones, bringing its total strength to nearly 4,800 examiners. Another 1,200 are due to be hired this year, he said. IPBiz notes that 4,000 + 1,200 = 5,200, not "nearly 4,800." See also an earlier IPBiz post on problems of employee retention at the USPTO: http://ipbiz.blogspot.com/2006/08/examiner-hiring-and-retention-at-uspto.html Separately, recall the numerous patents in the area of buckyballs and fullerenes which issued in the 1990's and went no where. cialis generic viagra online buy cilais viagra

Tags:

The Chicago Tribune goods Brazil correct transferred their drug costs to U.S. Folk. Too no, this has something to do with nanotechnology. Centrally located an hoopla this has been watched up patent geeks considering some age Brazil altogether shook ended Abbott Laboratories through minus tries latent Kaletra (Generic lopinavir ) a protease inhibitor in force in fighting HIV, the virus that causes aids. Kaletra alacrity whereas those with HIV this is resistant to succeeding protease inhibitors along doesn cheap cialis Cheap Viagra cialis buy cilais

Tags: hiv, drug, protease, inhibitor, brazil